MedPath

SWEDISH MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1910-01-01
Employees
-
Market Cap
-
Website
http://www.swedish.org/

Clinical Trials

39

Active:1
Completed:20

Trial Phases

5 Phases

Early Phase 1:2
Phase 1:7
Phase 2:11
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials

Not Applicable
13 (37.1%)
Phase 2
11 (31.4%)
Phase 1
7 (20.0%)
Early Phase 1
2 (5.7%)
Phase 4
2 (5.7%)

Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial

Not Applicable
Recruiting
Conditions
Primary Spontaneous Pneumothorax
First Posted Date
2024-05-13
Last Posted Date
2025-05-16
Lead Sponsor
Swedish Medical Center
Target Recruit Count
200
Registration Number
NCT06411431
Locations
🇺🇸

Swedish Cancer Institute, Seattle, Washington, United States

Minimally Invasive Esophagectomy Pain Control Trial

Phase 1
Recruiting
Conditions
Postoperative Complications
Postoperative Pain, Acute
First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Swedish Medical Center
Target Recruit Count
30
Registration Number
NCT05906134
Locations
🇺🇸

Swedish Cancer Institute, Seattle, Washington, United States

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Early Phase 1
Recruiting
Conditions
Newly Diagnosed Glioblastoma
Interventions
Drug: combinations of up to 3 FDA approved drugs from a panel of compounds
First Posted Date
2022-05-18
Last Posted Date
2025-05-16
Lead Sponsor
Swedish Medical Center
Target Recruit Count
10
Registration Number
NCT05380349
Locations
🇺🇸

Swedish Medical Center, Seattle, Washington, United States

Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy

Phase 2
Terminated
Conditions
Covid19
SARS-CoV Infection
First Posted Date
2020-09-09
Last Posted Date
2022-07-29
Lead Sponsor
Swedish Medical Center
Target Recruit Count
45
Registration Number
NCT04542993
Locations
🇺🇸

Swedish Medical Center, Seattle, Washington, United States

Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome

Phase 4
Withdrawn
Conditions
Levator Ani Syndrome
Interventions
First Posted Date
2020-01-03
Last Posted Date
2023-04-19
Lead Sponsor
Swedish Medical Center
Registration Number
NCT04216797
Locations
🇺🇸

Swedish Medical Center Colon Rectal Clinic, Seattle, Washington, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

News

Expanding Biologic Options Transform Treatment Landscape for Psoriatic Arthritis

Recent clinical trials demonstrate sustained efficacy of newer biologics like bimekizumab and risankizumab in treating psoriatic arthritis, expanding treatment options beyond traditional TNF inhibitors.

New Clinical Studies and Classification Criteria Advance Understanding of Axial PsA Treatment

Leading research reveals that axial inflammation affects up to 40% of psoriatic arthritis patients, prompting efforts to establish clearer diagnostic criteria based on clinical features, imaging findings, and genetic markers.

© Copyright 2025. All Rights Reserved by MedPath